Literature DB >> 6738264

Comparison of electrode sites in electrical stimulation of the cochlea.

H S Lusted, C Shelton, F B Simmons.   

Abstract

There is considerable controversy about the "best" location for single channel cochlear implant electrodes. We measured the electrically induced auditory brain stem response (EABR) in a series of normal to totally denervated cat ears in response to promontory (P), round window (RW) and scala tympani (ST) stimulation. The status of the ganglion cell population was then assessed by light microscopy. In ears with light to medium ganglion cell loss the ST EABR yielded the most definitive input-output functions. RW responses were present at increased thresholds and smaller peak amplitudes. P responses were worse or even missing completely. In severely damaged ears, including some with no detectable ganglion cells, ST and RW EABRs were both markedly reduced with considerable overlap between the two sites. P responses, when present, were almost buried in the electrical noise near threshold. Extrapolating these results to humans suggests that when ganglion cell loss is very severe the RW or ST is an acceptable stimulation site. When ganglion cell loss is moderate or better, ST electrodes are superior.

Entities:  

Mesh:

Year:  1984        PMID: 6738264     DOI: 10.1288/00005537-198407000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Electrically Evoked Auditory Brainstem Response over Round Window by Bipolar Stimulation.

Authors:  Noelia Munoz Fernandez; Carlos de Paula Vernetta; Laura Cavelle Garrido; Miguel Diaz Gomez; Constantino Morera Perez
Journal:  J Int Adv Otol       Date:  2018-12       Impact factor: 1.017

2.  Excitation of the Auditory System as a Result of Non-invasive Extra-Cochlear Stimulation in Normal Subjects and Tinnitus Patients.

Authors:  Marzena Mielczarek; Arnaud Norena; Winfried Schlee; Jurek Olszewski
Journal:  Front Neurosci       Date:  2018-03-23       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.